
<!DOCTYPE html>
<html lang="en">
<head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Seeking information on whether PLC code complies with FDA regulations regarding electronic records and signatures (21 CFR Part 11). Any input on this topic would be greatly valued.">
    <meta name="keywords" content="plc code compliance, fda regulations, electronic records, electronic signatures, 21 cfr part 11, fda compliance, pharma industry, plc code, understanding fda regulations, electronic records compliance, electronic signatures compliance, fda guidelines, plc code validation, fda">
    <meta name="author" content="oxmaint">
    
    <link rel="canonical" href="https://community.oxmaint.com/discussion-forum/understanding-fda-compliance-for-plc-code-in-pharma-industry">
    <title>Understanding FDA Compliance for PLC Code in Pharma Industry | Oxmaint Community</title>
    <link rel="shortcut icon" href="./../assets/img/favicon.png" />
    <link rel="stylesheet" href="./../assets/css/plugins.css" />
    <link rel="stylesheet" href="./../assets/css/style.css" />
    <link rel="stylesheet" href="./../assets/css/colors/purple.css" />
    
    <!-- og or twitter tags -->
    <meta property="og:type" content="article">
    <meta property="og:title" content="Understanding FDA Compliance for PLC Code in Pharma Industry | Oxmaint Community">
    <meta property="og:description" content="Seeking information on whether PLC code complies with FDA regulations regarding electronic records and signatures (21 CFR Part 11). Any input on this topic would be greatly valued.">
    <meta property="og:url" content="https://community.oxmaint.com/discussion-forum/understanding-fda-compliance-for-plc-code-in-pharma-industry">
    <meta property="og:site_name" content="Oxmaint">
    <meta property="og:image" content="https://community.oxmaint.com/assets/img/favicon.png">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:title" content="Understanding FDA Compliance for PLC Code in Pharma Industry | Oxmaint Community">
    <meta name="twitter:description" content="Seeking information on whether PLC code complies with FDA regulations regarding electronic records and signatures (21 CFR Part 11). Any input on this topic would be greatly valued.">
    <meta name="twitter:image" content="https://community.oxmaint.com/assets/img/favicon.png">

    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-Y6M0T9NLP4"></script>
    <script>
        window.dataLayer = window.dataLayer || [];
        function gtag() { dataLayer.push(arguments); }
        gtag('js', new Date());
        gtag('config', 'G-Y6M0T9NLP4');
    </script>

    <!-- Structured Data (Schema.org) -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "Article",
      "mainEntityOfPage": {
        "@type": "WebPage",
        "@id": "https://community.oxmaint.com/discussion-forum/understanding-fda-compliance-for-plc-code-in-pharma-industry"
      },
      "headline": "Understanding FDA Compliance for PLC Code in Pharma Industry",
      "description": "Seeking information on whether PLC code complies with FDA regulations regarding electronic records and signatures (21 CFR Part 11). Any input on this topic would be greatly valued.",
      "author": {
        "@type": "Person",
        "name": "MCW"
      },
      "publisher": {
        "@type": "Organization",
        "name": "Oxmaint",
        "logo": {
          "@type": "ImageObject",
          "url": "https://community.oxmaint.com/assets/img/favicon.png"
        }
      },
      "datePublished": "2024-09-18",
      "image": "https://community.oxmaint.com/assets/img/favicon.png"
    }
    </script>

<link href="https://assets.calendly.com/assets/external/widget.css" rel="stylesheet">
<script src="https://assets.calendly.com/assets/external/widget.js" type="text/javascript" defer></script>
<link rel="stylesheet" href="./../assets/css/home.css"/>
</head>
<body>
    <div class="content-wrapper bg-gray">
        <?php include "../include/header.php" ?>
        <!-- /header -->
        <div class="container my-5">
            

            <div class="bg-primary card p-4 mb-4">
                <h1 class="text-white">Understanding FDA Compliance for PLC Code in Pharma Industry</h1>
                <div class="d-flex justify-content-between">
                    <ul class="post-meta text-white fs-15 mb-4">
                        <li class="post-date"><i class="uil uil-calendar-alt"></i><span>18-09-2024</span></li>
                        <li class="post-author"><i class="uil uil-user"></i><span>MCW</span></li>
                        <li class="post-comments"><i class="uil uil-comment-alt-dots"></i><span>6 comments</span></li>
                        <li class="post-seen"><i class="uil uil-eye"></i><span id="counter">7480</span></li>
                        <li class="post-like"><i class="uil uil-thumbs-up" id="likeButton"></i><span id="likeCount">394</span></li>
                    </ul>
                </div>
                <div class="card p-4">
                    <h3>Question:</h3>
                    <p>Seeking information on whether PLC code complies with FDA regulations regarding electronic records and signatures (21 CFR Part 11). Any input on this topic would be greatly valued.</p>
                </div>
            </div>

            <div class="row custom-row">
                <div class="col-lg-9 mx-auto mb-5">
                    <div>
                        <div class="p-4">
                            <h3 class="text-primary">Top Replies</h3>
                            
        <div class="bg-white p-3 rounded mb-3">
            <p>Do you wish to delve into this topic? The truth is, uncertainty reigns – no one holds all the answers. Your query unravels into various layers, and I shall endeavor to navigate through them. While I may not be a Part 11 expert, my company boasts several experts, and my interactions with them have shed light on Part 11 compliance. 
When it comes to "Electronic Signatures", it's important to note that PLCs are not designed for direct human interaction. Electronic signatures must be obtained via SCADA/HMI systems, which ultimately communicate with humans. Therefore, the responsibility falls on SCADA/HMI to ensure Part 11 compliance.
Regarding "Electronic Batch Records", PLCs have limited memory capacity and are not ideal for storing extensive historical data. It is typically the SCADA system that retains vast amounts of information. Even if PLCs were to store batch records over multiple years, data integrity becomes a critical concern in ensuring compliance with Part 11 regulations. 
An essential aspect of Part 11 involves maintaining an audit trail for electronic records to trace any alterations back to their source. The system must be secure from unauthorized tampering. The ideal Part 11 system operates similarly to an ATM, where transactions are secure, and access is restricted to authorized personnel.
Certain ambiguities persist in Part 11 compliance, such as the usage of tokens for electronic signatures. The FDA is yet to provide clear guidelines on whether both tokens must be entered for each transaction or if a single token suffices as acknowledgement. This uncertainty has left pharmaceutical companies and SCADA manufacturers grappling with the best approach.
Each pharmaceutical entity interprets Part 11 regulations differently, adding to the complexity of compliance. Ultimately, it is crucial to understand that no PLC can achieve full Part 11 compliance.</p>
            <ul class="post-meta mb-0">
                <li class="post-date"><i class="uil uil-calendar-alt"></i><span>19-09-2024</span></li>
                <li class="post-author"><i class="uil uil-user"></i><span>Allen Nelson</span></li>
            </ul>
        </div>
        
        <div class="bg-white p-3 rounded mb-3">
            <p>I have experience creating PC-based programs that emulate PLCs for pharmaceutical packaging in a major company located in Roanoke, Virginia. This process focused on sealing the container surface, not the product itself. Unfortunately, I am unable to recall the specific company or specification you are inquiring about at this time.</p>
            <ul class="post-meta mb-0">
                <li class="post-date"><i class="uil uil-calendar-alt"></i><span>20-09-2024</span></li>
                <li class="post-author"><i class="uil uil-user"></i><span>Terry Woods</span></li>
            </ul>
        </div>
        
        <div class="bg-white p-3 rounded mb-3">
            <p>Terry Woods shared his experience of developing PC-based, PLC-Emulating programs for packaging in the Pharmaceutical industry, specifically focusing on container seal surface finishing. This project took place around 1999 when Part 11 was added to 21 CFR. If the packaging line required validation, it would likely fall under cGMP regulations. Many HVAC systems are now undergoing retro-validation due to their impact on product quality. Validation is crucial in ensuring that the product meets its intended specifications and functions correctly.</p>
            <ul class="post-meta mb-0">
                <li class="post-date"><i class="uil uil-calendar-alt"></i><span>21-09-2024</span></li>
                <li class="post-author"><i class="uil uil-user"></i><span>Allen Nelson</span></li>
            </ul>
        </div>
        
        <div class="bg-white p-3 rounded mb-3">
            <p>I believe Allen's response was accurate. While PLC systems cannot achieve compliance with Part 11 regulations, it is the responsibility of the SCADA system to do so. Our company specializes in manufacturing packaging machines for the pharmaceutical industry, equipped with either a SCADA-type HMI or simpler interfaces like Siemens TP170 or Bradley PanelView. These systems all feature password protection, although our clients have deemed this to be sufficient without the need for usernames. Additionally, our machines undergo thorough validation processes, ranging from meeting 2000 compliance standards to considering various sensor failure scenarios. During acceptance inspections, our clients bring in experts from multiple fields, leaving me to handle their inquiries alone. Perhaps it is time to discuss a potential raise with my boss.</p>
            <ul class="post-meta mb-0">
                <li class="post-date"><i class="uil uil-calendar-alt"></i><span>22-09-2024</span></li>
                <li class="post-author"><i class="uil uil-user"></i><span>paraffin power</span></li>
            </ul>
        </div>
        
        <div class="bg-white p-3 rounded mb-3">
            <p>PLCs and Compliance with 21 CFR Part 11

When it comes to PLCs, the software is classified as an electronic record according to FDA regulations. However, PLC Software currently lacks compliance in certain areas, such as the absence of an electronic audit trail for changes. PLCs and DCSs play a crucial role in the pharmaceutical industry by automating manufacturing processes, often without the use of SCADA or HMI systems.

To ensure compliance, GxP systems must undergo validation, implement security measures to restrict access to PLC code, and establish change control procedures. Regular software checks should be conducted to detect unauthorized changes, and maintaining previous software versions can aid in compliance efforts.

While there have been no FDA warning letters specifically targeting the use of PLCs, systems lacking adequate controls are at risk. SCADA systems and HMIs require separate assessments to ensure compliance with regulatory requirements.</p>
            <ul class="post-meta mb-0">
                <li class="post-date"><i class="uil uil-calendar-alt"></i><span>22-09-2024</span></li>
                <li class="post-author"><i class="uil uil-user"></i><span>BarryT</span></li>
            </ul>
        </div>
        
                        </div>
                        <div class="p-4">
    <h3 class="text-primary">
        <a href="#" class="toggle-more-replies" style="text-decoration: underline; color: #1a73e8; cursor: pointer;">More Replies →</a>
    </h3>
    <div class="more-replies-content" style="display: none;">
                            
        <div class="bg-white p-3 rounded mb-3">
            <p>What is an AI bot and how does it work? Learn about the capabilities and functions of artificial intelligence bots.</p>
            <ul class="post-meta mb-0">
                <li class="post-date"><i class="uil uil-calendar-alt"></i><span>22-09-2024</span></li>
                <li class="post-author"><i class="uil uil-user"></i><span>Robobob</span></li>
            </ul>
        </div>
        
                        </div>
                    <div class="no-replies-message" style="display: none; color: gray;">
        No More Replies.
    </div>
        
                        </div>
                    </div>
                </div>
                <div class="col-lg-3 outer-container">
        <!-- Related Topics -->
    <?php include "./related-topic.php" ?>
    </div>
            </div>
             <!-- cta button -->
        <?php include "./cta.php" ?>

            <!-- FAQ Section -->
            <div class='my-5'><h3 class='faq-title text-primary mb-4'>Frequently Asked Questions (FAQ)</h3>
<div class='faq-item bg-light p-4 rounded shadow-sm mb-3'>
<h4 class='text-dark'>FAQ: FAQs:</h4>
<p class='text-muted'><strong>Answer:</strong> 1. What are the key considerations for ensuring PLC code compliance with FDA regulations, specifically 21 CFR Part 11?
- The key considerations include ensuring electronic records are secure, accurate, and accessible, along with implementing controls for electronic signatures and audit trails.</p>
</div>
<div class='faq-item bg-light p-4 rounded shadow-sm mb-3'>
<h4 class='text-dark'>FAQ: 2. How can the pharmaceutical industry ensure that PLC code meets FDA compliance requirements for electronic records and signatures?</h4>
<p class='text-muted'><strong>Answer:</strong> - The pharmaceutical industry can ensure compliance by following best practices such as validation of PLC code, maintaining documentation, implementing security measures, and training personnel on compliance requirements.</p>
</div>
<div class='faq-item bg-light p-4 rounded shadow-sm mb-3'>
<h4 class='text-dark'>FAQ: 3. Are there specific guidelines or standards that address FDA compliance for PLC code in the pharmaceutical industry?</h4>
<p class='text-muted'><strong>Answer:</strong> - Yes, the FDA's 21 CFR Part 11 provides specific regulations for electronic records and signatures, which apply to PLC code used in the pharmaceutical industry.</p>
</div>
<div class='faq-item bg-light p-4 rounded shadow-sm mb-3'>
<h4 class='text-dark'>FAQ: 4. What are the consequences of non-compliance with FDA regulations for PLC code in the pharma industry?</h4>
<p class='text-muted'><strong>Answer:</strong> - Non-compliance can lead to regulatory action, fines, product recalls, and damage to the reputation of pharmaceutical companies. It is essential to adhere to FDA regulations to ensure patient safety and data integrity.</p>
</div>
</div>
        </div>
        <?php include "./footer-banner.php" ?>

        <!-- /footer -->
        <?php include "../include/footer.php" ?>

        <script src="like-view-counter.js"></script>
    </div>
<script>
document.addEventListener("DOMContentLoaded", () => {
    function initializeToggleFunctionality() {
        const toggleLink = document.querySelector(".toggle-more-replies");
        const moreRepliesContent = document.querySelector(".more-replies-content");
        const noRepliesMessage = document.querySelector(".no-replies-message");

        if (!toggleLink || !moreRepliesContent || !noRepliesMessage) {
            console.error("Required elements not found. Ensure the correct class names are used.");
            console.log({
                toggleLink,
                moreRepliesContent,
                noRepliesMessage,
            });
            return;
        }

        const hasReplies = Array.from(moreRepliesContent.children).some(
            (child) => child.nodeType === Node.ELEMENT_NODE
        );

        if (hasReplies) {
            noRepliesMessage.style.display = "none";
        } else {
            noRepliesMessage.style.display = "block";
            toggleLink.style.display = "none";
            return;
        }

        toggleLink.addEventListener("click", (event) => {
            event.preventDefault();
            const isHidden = getComputedStyle(moreRepliesContent).display === "none";
            moreRepliesContent.style.display = isHidden ? "block" : "none";
            toggleLink.textContent = isHidden ? "Hide More Replies" : "More Replies →";
        });
    }

    initializeToggleFunctionality();

    const observer = new MutationObserver(() => {
        const toggleLink = document.querySelector(".toggle-more-replies");
        const moreRepliesContent = document.querySelector(".more-replies-content");

        if (toggleLink && moreRepliesContent) {
            initializeToggleFunctionality();
            observer.disconnect();
        }
    });

    observer.observe(document.body, { childList: true, subtree: true });
});
</script>
</body>
</html>
